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LETTERS TO THE EDITOR
Vascular Effect of Insulin
in Endothelial Dysfunction
We read with interest the article by Hirashima et al. (1) in a recent
issue of the Journal. The investigators report on the effect of
vitamin C on endothelial function and insulin sensitivity in
patients with coronary spastic angina, and they present further
evidence that endothelial function might be one of the factors
regulating insulin sensitivity. We would like to add some com-
ments about the insulin-endothelium interplay.
Hirashima et al. (1) argue that endothelium mediates insulin
resistance merely indirectly, via impaired vasodilator capacity, leading
to a reduced supply of both insulin and glucose to the glucose utilizing
tissues such as skeletal muscle. It might also be added that endothe-
lium itself is an insulin-sensitive tissue, and the direct vasodilator effect
of insulin-stimulating endothelial nitric oxide release (2,3) may further
amplify the glucose utilization of the peripheral tissue.
Accordingly, under conditions of endothelial dysfunction a
reduced vasodilator effect of insulin has been reported (4). We
were surprised, however, that Hirashima et al. (1) report no
changes in hemodynamics in both controls and patients during the
insulin-sensitivity test. This finding has not been discussed by the
researchers. From the amount of insulin and glucose administered
according to the protocol, one would have expected to see a
vasodilator effect, particularly in control subjects. A difference
between the control group and patients with impaired endothelial
function would seem plausible. Moreover, a recovery of insulin-
mediated vasodilation through improvement of the cellular redox
state (such as vitamin C supplementation) would strongly support
the current opinion of insulin’s direct effect on endothelial function
regulating vascular tone.
We have previously shown that in healthy control subjects, but
not in patients with coronary artery disease, forearm blood flow
increases after an intravenous administration of glucose (5). The
amount of glucose administered in our study (0.5 g/kg) was similar
to the amount of glucose administered by Hirashima et al. (1).
Although we gave glucose as a bolus, a vasodilator effect on
forearm blood flow for up to 180 min was recorded.
One explanation for the different finding in this study could be
the method employed for assessment of insulin sensitivity. By
suppressing endogenous insulin response to a glucose stimulus
with sandostatin, the closed feedback loop by which glucose and
insulin concentrations mutually modify one another is interrupted.
It is uncertain whether the blockade of endogenous insulin
secretion or the unphysiologic steady state may also affect other
insulin-related pathways, such as the insulin-mediated augmenta-
tion of endothelium-dependent vasodilation.
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Electron Beam Computed
Tomography in the Diagnosis of
Obstructive Coronary Artery Disease
We congratulate the authors of the recent American College of
Cardiology/American Heart Association Expert Consensus Doc-
ument on Electron-Beam Computed Tomography (EBCT) for
the Diagnosis and Prognosis of Coronary Artery Disease (CAD)
on the publication of a fair and balanced review of the utility of
EBCT in CAD (1). However, we would like to highlight four
methodological limitations in their meta-analysis of the diagnostic
accuracy of EBCT in obstructive CAD.
First, the authors state that after contacting investigators of the
included studies, only two reports were excluded due to consider-
able patient overlap. Based on our communication with several of
the investigators of these same reports, we believe there are
additional studies that should have been excluded due to patient
overlap. For instance, we know that all 491 subjects in the report
by Detrano et al. (2) were later included in the multicenter analysis
by Budoff et al. (3) (n 5 710) (Detrano R, personal communica-
tion, July 1999), and that the studies by Bielak et al. (4) and
Kaufmann et al. (5) had 100% patient overlap (Bielak LF, personal
communication, May 1999). After eliminating other studies with
potential overlap ($50% overlap), we speculate that the Consensus
Document overestimates the total number of subjects who have
been studied with EBCT by almost one-third.
Second, it should be noted that the multicenter study by Budoff
et al. (3), which is the largest single study in the meta-analysis,
contains data from six institutions, each of which used indepen-
dent protocols for performing EBCT examinations and for defin-
ing calcium on an EBCT film. Therefore, it would have been more
appropriate to use center-specific data from each institution to
calculate summary odds ratios and a summary receiver-operating-
characteristic curve.
Third, we agree with the authors that the inclusion of reports
that used diverse methods for assessing CAD, such as intravascular
ultrasound (6) or historical information (history of prior myocar-
dial infarction) (7), in their meta-analysis is likely to lead to
substantial heterogeneity and inexact summary estimates. Finally,
we know of at least three published studies missing from the
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